Older donor allografts are associated with poor patient survival after living donor liver transplantation for hepatitis B virus-related liver diseases

Liver International

Volumn 27, Issue 2, 2007, Pages 260-267

  Kim, Do Young ^a   Choi, Moon Seok ^a   Lee, Joon Hyoek ^a   Koh, Kwang Cheol ^a   Paik, Seung Woon ^a   Yoo, Byung Chul ^a   Joh, Jae Won ^a   Lee, Suk Koo ^a   Rhee, Jong Chul ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Hepatitis B virus; Liver transplantation; Older donor; Survival

Indexed keywords

ALANINE AMINOTRANSFERASE; CORTICOSTEROID; CYCLOSPORIN; GANCICLOVIR; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; LAMIVUDINE; METHYLPREDNISOLONE; OKT 3; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; HEPATITIS B CORE ANTIGEN;

ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC LIVER DISEASE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER LOBECTOMY; LIVER TRANSPLANTATION; LIVING DONOR; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; RISK FACTOR; SURGICAL MORTALITY; SURVIVAL RATE; AGE; ALLOTRANSPLANTATION; BLOOD; IMMUNOLOGY; MIDDLE AGED; MORTALITY; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGE FACTORS; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 34247592977     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.01403.x     Document Type: Article

References (21)

1. Ghobrial RM, Steadman R, Gornbein J, et al. A ten-year experience of liver transplantation for hepatitis C: Analysis of factors determining outcome in over 500 patients. Ann Surg 2001; 234(3): 384-93.
2. Yersiz H, Shaked A, Olthoff K, et al. Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation 1995; 60(8): 790-4.
3. Alexander JW, Vaughn WK. The use of "marginal donors" for organ transplantation. The influence of donor age on outcome. Transplantation 1991; 51(1): 135-41.
4. Wright TL, Donegan E, Hsu HH, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103(1): 317-22.
5. Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334(13): 815-20.
6. Prieto M, Berenguer M, Rayon JM, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype Ib infection following transplantation: Relationship with rejection episodes. Hepatology 1999; 29(1): 250-6.
7. Berenguer M, Prieto M, San Juan F, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002; 36(1): 202-10.
8. Wali M, Harrison RF, Gow PJ, Mutimer D. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 2002; 51(2): 248-52.
9. Machicao VI, Bonatti H, Krishna M, et al. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 2004; 77(1): 84-92.
10. Lok AS Prevention of recurrent hepatitits B post-liver transplantation. Liver Transplant 2002; 8(10 Suppl. 1): S67-70.
11. Park SJ, Paik SW, Choi MS, et al. Is lamivudine with 1-week HBIg as effective as long-term high dose HBIg in HBV prophylaxis after liver transplantation? Transplant Proc 2002; 34(4): 1252-4.
12. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33(6): 1394-403.
13. Condron SL, Heneghan MA, Patel K, Dev A, Mchutchison JG, Muir AJ. Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection. Transplantation 2005; 80(1): 145-8.
14. Baccarani U, Adani GL, Toniutto P, et al. Liver transplantation from old donors into HCV and non-HCV recipients. Transplant Proc 2004; 36(3): 527-8.
15. Wall WJ, Mimeault R, Grant DR, Bloch M. The use of older donor livers for hepatic transplantation. Transplantation 1990; 49(2): 377-81.
16. Washburn WK, Johnson LB, Lewis WD, Jenkins RL. Graft function and outcome of older (≥60 years) donor livers. Transplantation 1996; 61(7): 1062-6.
17. Buckel E, Sanchez-Urdazpal L, Steers J, Sterioff S, Wiesner R, Krom RA. Impaired initial function in liver grafts from donors >50 years of age. Transplant Proc 1993; 25: 1558-9.
18. Busquets J, Xiol X, Figueras J, et al. The impact of donor age on liver transplantation: Influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation 2001; 71(12): 1765-71.
19. Kiuchi T, Tanaka K, Ito T, et al. Small-for-size graft in living donor liver transplantation: How far should we go? Liver Transplant 2003; 9: S29-35.
20. Hoofnagle JH, Lombardero M, Zettermann RK, et al. Donor age and outcome of liver transplantation. Hepatology 1996; 24(1): 89-96.
21. Marino IR, Doyle HR, Aldrighetti L, et al. Effect of donor age and sex on the outcome of liver transplantation. Hepatology 1995; 22(6): 1754-62.